Retrovirus Testing Market: Overview
Retrovirus consists of an enzyme known as the reverse transcriptase in the single-stranded RNA virus. It is with the help of the reverse transcriptase that the retroviral RNA gets transcribed into the retroviral DNA after it enters the host cell.
Retrovirus Testing Market: Facts
It is estimated that several millions of American people are infected with the retrovirus which is the root cause of several chronic diseases. In a presentation, it was suggested that XMRV (xenotropic murine leukemia virus-related virus) which is a type of retrovirus is found in more than half of the CFS patients. Owing to which the patients are having higher chances of contracting Chronic Fatigue Syndrome, Lou Gehrig’s Disease, Lyme’s Disease, prostate cancer, autism, and Parkinson’s Disease.
Retrovirus Testing Market: Segmentation
The global market for the retrovirus testing is fragmented into its test type, technique, sample, and end-user industry. Based on the type of the test, the global market is segregated into product-enhanced reverse transcriptase (PERT) assay, transmission electron microscopy, western blot analysis, serological tests, infectivity assay, co-cultivation assay, radio-immunoassay, and immunofluorescence. Based on the type of the technique, the market is categorized into enzyme linked immunosorbent assay, high-throughput screening, and polymerase chain reaction. Based on the type of the sample, the market is divided into serum, cells, blood, and body fluids. Based on the end-user industry, the market is bifurcated into clinics, hospitals, and diagnostic laboratories and centers.
Retrovirus Testing Market: Growth Factors
The key factors that are driving the growth of the retrovirus testing market are the quick results that are provided by the retrovirus testing, kits and assays that are an efficient diagnostic tool for retrovirus testing, and the increased availability of high-end retrovirus screening instruments. The other factors that are fuelling the growth of the market are the introduction to the advanced retroviral infection detection technologies, the rise in the awareness about the diagnostic tests, and the rise in the investments that are made in the research and the development activities for the retrovirus screening. There is an increased demand for the retrovirus testing in the diagnostic laboratories and the hospitals thus increasing the demand of the market. The factors that will limit the growth of the market are the absence of the trained professionals in order to execute the sensitive assays and the increased costs of the diagnostic kits and assays.
Retrovirus Testing Market: Regional Analysis
The maximum market share in the retrovirus testing market is held by the North America owing to the increasing R & D activities for the early detection of the retrovirus infection in the human body. Europe holds the second position in the retrovirus testing market. In the coming years, the market in Asia Pacific region will experience a strong growth and will produce high revenue.
Retrovirus Testing Market: Competitive Players
The key market players that are involved in the retrovirus testing market include Alere Inc., DiaSorin S.p.A., Becton, Abbott Diagnostics, Roche Diagnostics Ltd., bioMérieux SA, Dickinson and Company, and others.
Retrovirus Testing Market: Regional Segment Analysis
What Reports Provides